SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs, today announced that it will host a live webcast on Wednesday, August 9, 2023, at 4:30 p.m. Eastern Time to discuss the Company’s financial results for the second quarter ended June 30, 2023, and provide a general business update.
Webcast Information
Date : Wednesday, August 9, 2023
Time : 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
Webcast Link : https://lifescievents.com/event/belitebio/
Webcast Link Instructions
You can join the live webcast by visiting the link above or the “Presentations & Events” section of the Company’s Investor Relations website at https://investors.belitebio.com/presentations-events/events . A replay will be available approximately two hours after the event for 90 days.
About Belite Bio
Belite Bio is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases with significant unmet medical needs, such as Stargardt disease and Geographic Atrophy in advanced Age-Related Macular Degeneration, in addition to specific metabolic diseases. For more information, follow us on Twitter , Instagram , LinkedIn , Facebook or visit us at www.belitebio.com .
Media and Investor Relations Contacts
Jennifer Wu /ir@belitebio.com
Tim McCarthy /tim@lifesciadvisors.com